Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patients

Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patients. Lévesque, H.; Viallard, J. F.; Houivet, E.; Bonnotte, B.; Voisin, S.; Le Cam-Duchez, V.; Maillot, F.; Lambert, M.; Liozon, E.; Hervier, B.; Fain, O.; Guillet, B.; Schmidt, J.; Luca, L. E.; Ebbo, M.; Ferreira-Maldent, N.; Babuty, A.; Sailler, L.; Duffau, P.; Barbay, V.; Audia, S.; Benichou, J.; Graveleau, J.; Benhamou, Y.; CREHA Study investigators on behalf the scientific committee of the “Société Nationale Française de Médecine Interne” (SNFMI – French National Society of Internal Medicine). Thrombosis Research. 2024; 237: p.79-87. doi:10.1016/j.thromres.2024.03.012
Article